Vena cava stenting and portorenal shunt in Budd-Chiari syndrome: combination of the 'modern' and the 'classical'.
We have treated a 33-year-old Budd-Chiari patient (due to antiphospholipid syndrome) with a history of myocardial infarction by placing a vascular stent in the inferior vena cava and performing a portorenal shunt with three objectives: (1) to perform a shunt operation on a Budd-Chiari patient with good hepatic functional reserve, (2) to avoid a thoracotomy and manipulation of the heart in a patient with a cardiac thrombus and a history of myocardial infarction and (3) to avoid a synthetic graft in a patient with antiphospholipid syndrome. Vena cava stenting and portorenal shunt make a useful combination which should be included in the armamentarium of the hepatobiliary surgeon.
Emre
A
A
Hepatopancreatobiliary Surgery Unit, Department of Surgery, Istanbul Faculty of Medicine, Istanbul, Turkey. hpbcer@superonline.com
Ozden
I
I
Poyanli
A
A
Bilge
O
O
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage; D006502:Budd-Chiari Syndrome / Q000175:diagnosis / Q000601:surgery*; D003251:Constriction, Pathologic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D011167:Portacaval Shunt, Surgical; D015607:Stents; D014682:Vena Cava, Inferior / Q000473:pathology / Q000601:surgery*; D014859:Warfarin / Q000008:administration & dosage
D000925:Anticoagulants; D014859:Warfarin